VetPrev Competitors

Our story began in 2010 with a realization: loving your pet is the easy part. Figuring out how to care for them without spending a small fortune? That's a whole other story. We believe that pet parents should be able to raise their pets without feeling like it’s out of reach. PetIQ started by manufacturing affordable health supplements and flea and tick solutions and has since grown into a portfolio that includes jerky treats, stain and odor removers, dental treats, and a wide range of health and wellness products. Today, our branded products are sold online and in stores at Amazon, Walmart, PetSmart, Chewy, and wherever else our customers shop for their pets. We are headquartered in beautiful Eagle, Idaho. Our products are manufactured in facilities across the U.S., including Springville, Utah and Omaha, Nebraska. Do you love pets and want to make a difference? Whether you work in our corporate office or manufacturing facilities, there is a place for you at PetIQ. Join the pack! Meet Our Brands PetArmor • CAPSTAR • Minties • Vet IQ • Pūr Luv • Rocco & Roxie • NextStar

At Vetsource®, we build the foundation for success, enabling pet healthcare professionals to thrive. Our data-powered platform simplifies processes and enriches communication, helping veterinary teams create tighter bonds with pet owners. Page subject to vetsource.com/terms-of-use and vetsource.com/privacy-policy. Vetsource is not responsible for content or activity made available via 3rd party sites/services.

FidoCure® is an AI-driven personalized therapeutics engine for canine cancer, developed by One Health Company. Leveraging the genetic similarities between canine and human cancers, FidoCure combines genomic, clinical, and real-world evidence to help veterinarians make more informed, individualized treatment decisions. Through its proprietary next-generation DNA sequencing test, FidoCure has built the world’s largest canine cancer genomics dataset, enabling more effective and accessible targeted therapies. FidoCure’s work has been published in Nature Precision Oncology and Nature Scientific Reports. Backed by leading biotech investors including Polaris Ventures, Andreessen Horowitz (a16z), and Y Combinator, FidoCure is advancing personalized cancer care for dogs while generating insights relevant to human health.